Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-001345
Filing Date
2025-01-10
Accepted
2025-01-10 21:36:34
Documents
1
Period of Report
2025-01-07

Document Format Files

Seq Description Document Type Size
1 form4-01112025_020131.html 4  
1 form4-01112025_020131.xml 4 17771
  Complete submission text file 0001415889-25-001345.txt   19173
Mailing Address 800 BRIDGE PARKWAY REDWOOD CITY CA 94065
Business Address 800 BRIDGE PARKWAY REDWOOD CITY CA 94065 240-327-0603
Arcellx, Inc. (Issuer) CIK: 0001786205 (see all company filings)

EIN.: 472855917 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 25 WEST WATKINS MILL ROAD, SUITE A GAITHERSBURG MD 20878
Business Address
Gilson Michelle (Reporting) CIK: 0001930862 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41259 | Film No.: 25524544